Profusa (PFSA) Debt Ratio (2021 - 2026)

Profusa (PFSA) reported Debt Ratio of 8.14 for Q1 2026, down 39.27% on a YoY basis from 13.41 in Q1 2025, and up 73097.71% quarter-over-quarter from 0.01 in Q4 2025.

Profusa (PFSA) Debt Ratio (2021 - 2026) Analysis & Trends

Profusa has reported Debt Ratio for 5 years, with the latest figure at 8.14 in Q1 2026.

  • For the quarter ending Q1 2026, Debt Ratio fell 39.27% year-over-year to 8.14; the trailing twelve-month figure through Mar 2026 stood at 8.14 (down 39.27% YoY), and the FY2025 full-year result was 0.01, down 99.93% from the prior year.
  • Debt Ratio for Q1 2026 stood at 8.14, up from 0.01 in the prior quarter.
  • The five-year high for Debt Ratio was 14.94 in Q4 2024, with the low at 0.0 in Q2 2022.
  • Historically, Debt Ratio has averaged 4.69 across 4 years, with a median of 0.51 in 2025.
  • Annual changes were most pronounced in 2022 — Debt Ratio surged 1436.57% — and 2025, when it slumped 99.93%.
  • Profusa's Debt Ratio stood at 0.0 in 2022, then jumped by 11639983.53% to 14.94 in 2024, then tumbled by 99.93% to 0.01 in 2025, then surged by 73097.71% to 8.14 in 2026.
  • The last three Debt Ratio figures came in at 8.14 (Q1 2026), 0.01 (Q4 2025), and 1.01 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.31
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.32
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.31
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.25
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.04
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.30
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.27
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.18
10 Profusa 1.37 Mn 1.37 Mn - 8.14

Historic Data

Download Data
DateValue
Mar 31, 2026 8.14
Dec 31, 2025 0.01
Sep 30, 2025 1.01
Mar 31, 2025 13.41
Dec 31, 2024 14.94
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Dec 31, 2021 0.00